Imulan BioTherapeutics LLC has formed a company called Veterinary Cancer Therapeutics, located at the Imulan headquarters within the Christopher S. “Kit” Bond Science and Technology Incubator in St. Joseph, Mo.
The goal is to advance the company’s comparative veterinary oncology programs and commercialize several new immune activating technologies for treatment of cancer in dogs, cats and horses.
Veterinary Cancer Therapeutics will focus on the power of the immune system to fight cancer, according to the recently launched website.
“Mother Nature designed the most powerful tool against cancer in the form of the immune system,” said Craig Woods, DVM, chief executive officer of Imulan and Veterinary Cancer Therapeutics. “Many forms of cancer trick the immune system by producing factors that create a chemical camouflage and thus evade immune detection. Imulan is currently working on cutting-edge ways of making cancer visible to immune cells, giving the patient the upper hand.”
Veterinary Cancer Therapeutics will provide veterinarians with access to technology platforms by creating a treatment network.
A new laboratory to advance the company’s tumor biology and comparative oncology science programs is in the works.